Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Celcuity Inc., 3 years.
Celcuity Inc.
Director
Atea Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Atea Pharmaceuticals Inc. | Option exercise | +29,600 | — | — |
| Jun 5, 2026 | Celcuity Inc. | Grant or award | +1,530 | — | — |
| Jun 20, 2025 | Atea Pharmaceuticals Inc. | Option exercise | +29,600 | — | — |
| May 18, 2025 | Atea Pharmaceuticals Inc. | Open-market purchase | +6,100 | $4.17 | $25,437 |
| Jun 16, 2024 | Atea Pharmaceuticals Inc. | Option exercise | +33,150 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.